nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—Retinoids—Tazarotene—psoriasis	0.28	0.5	CiPCiCtD
Adapalene—Retinoids—Acitretin—psoriasis	0.28	0.5	CiPCiCtD
Adapalene—RARG—Tazarotene—psoriasis	0.0441	0.125	CbGbCtD
Adapalene—RXRB—Tazarotene—psoriasis	0.0389	0.11	CbGbCtD
Adapalene—RARB—Tazarotene—psoriasis	0.0389	0.11	CbGbCtD
Adapalene—RARA—Tazarotene—psoriasis	0.0389	0.11	CbGbCtD
Adapalene—RXRG—Acitretin—psoriasis	0.0348	0.0985	CbGbCtD
Adapalene—RARG—Acitretin—psoriasis	0.0348	0.0985	CbGbCtD
Adapalene—RXRB—Acitretin—psoriasis	0.0308	0.0871	CbGbCtD
Adapalene—RXRA—Acitretin—psoriasis	0.0308	0.0871	CbGbCtD
Adapalene—RARB—Acitretin—psoriasis	0.0308	0.0871	CbGbCtD
Adapalene—RARA—Acitretin—psoriasis	0.0308	0.0871	CbGbCtD
Adapalene—RXRB—Vitamin D Metabolism—VDR—psoriasis	0.000769	0.0322	CbGpPWpGaD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.000416	0.0174	CbGpPWpGaD
Adapalene—RXRA—Vitamin D Metabolism—VDR—psoriasis	0.000401	0.0168	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.000381	0.0159	CbGpPWpGaD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.000374	0.0156	CbGpPWpGaD
Adapalene—RARG—Retinoic acid receptors-mediated signaling—VDR—psoriasis	0.000371	0.0155	CbGpPWpGaD
Adapalene—RXRG—Regulation of Androgen receptor activity—REL—psoriasis	0.000366	0.0153	CbGpPWpGaD
Adapalene—RXRG—Regulation of Androgen receptor activity—CARM1—psoriasis	0.000361	0.0151	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.000358	0.015	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.000358	0.015	CbGpPWpGaD
Adapalene—RXRB—Regulation of Androgen receptor activity—REL—psoriasis	0.000344	0.0144	CbGpPWpGaD
Adapalene—RXRG—Retinoic acid receptors-mediated signaling—VDR—psoriasis	0.00034	0.0142	CbGpPWpGaD
Adapalene—RXRB—Regulation of Androgen receptor activity—CARM1—psoriasis	0.000339	0.0142	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000336	0.0141	CbGpPWpGaD
Adapalene—RXRA—REV-ERBA represses gene expression—CARM1—psoriasis	0.000333	0.0139	CbGpPWpGaD
Adapalene—RARB—Retinoic acid receptors-mediated signaling—VDR—psoriasis	0.000333	0.0139	CbGpPWpGaD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000328	0.0137	CbGpPWpGaD
Adapalene—RXRA—RORA activates circadian gene expression—CARM1—psoriasis	0.000323	0.0135	CbGpPWpGaD
Adapalene—RXRB—Retinoic acid receptors-mediated signaling—VDR—psoriasis	0.000319	0.0134	CbGpPWpGaD
Adapalene—RARA—Retinoic acid receptors-mediated signaling—VDR—psoriasis	0.000319	0.0134	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors—VDR—psoriasis	0.000307	0.0129	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000301	0.0126	CbGpPWpGaD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.00029	0.0121	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000289	0.0121	CbGpPWpGaD
Adapalene—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—CARM1—psoriasis	0.000286	0.012	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptors—VDR—psoriasis	0.000281	0.0118	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors—VDR—psoriasis	0.000276	0.0115	CbGpPWpGaD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000266	0.0111	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.000266	0.0111	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors—VDR—psoriasis	0.000264	0.0111	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—VDR—psoriasis	0.000264	0.0111	CbGpPWpGaD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.00026	0.0109	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.00025	0.0104	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.00025	0.0104	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000243	0.0102	CbGpPWpGaD
Adapalene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.000236	0.00986	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000234	0.00979	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000222	0.00929	CbGpPWpGaD
Adapalene—RXRA—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.000221	0.00926	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000218	0.00911	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors—PPARG—psoriasis	0.000214	0.00896	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00021	0.00879	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000209	0.00873	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000209	0.00873	CbGpPWpGaD
Adapalene—Skin irritation—Hydrocortisone—psoriasis	0.000202	0.00329	CcSEcCtD
Adapalene—RXRA—Transcriptional activation of mitochondrial biogenesis—CARM1—psoriasis	0.000202	0.00843	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000201	0.00842	CbGpPWpGaD
Adapalene—Herpes simplex—Acitretin—psoriasis	0.000201	0.00327	CcSEcCtD
Adapalene—Herpes simplex—Fluocinolone Acetonide—psoriasis	0.0002	0.00326	CcSEcCtD
Adapalene—Application site pain—Hydrocortisone—psoriasis	0.000199	0.00324	CcSEcCtD
Adapalene—Dry skin—Fluocinonide—psoriasis	0.000197	0.0032	CcSEcCtD
Adapalene—RXRG—Nuclear Receptors—PPARG—psoriasis	0.000196	0.0082	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors—PPARG—psoriasis	0.000192	0.00804	CbGpPWpGaD
Adapalene—RXRA—The citric acid (TCA) cycle and respiratory electron transport—NDUFA5—psoriasis	0.000188	0.00787	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.000187	0.0078	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—PPARG—psoriasis	0.000184	0.00771	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors—PPARG—psoriasis	0.000184	0.00771	CbGpPWpGaD
Adapalene—Dermatitis contact—Fluocinolone Acetonide—psoriasis	0.000182	0.00297	CcSEcCtD
Adapalene—Sunburn—Methotrexate—psoriasis	0.00018	0.00293	CcSEcCtD
Adapalene—RXRA—Regulation of Androgen receptor activity—REL—psoriasis	0.00018	0.00751	CbGpPWpGaD
Adapalene—Dermatitis bullous—Methoxsalen—psoriasis	0.000177	0.00289	CcSEcCtD
Adapalene—RXRA—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.000177	0.00739	CbGpPWpGaD
Adapalene—RXRA—Regulation of Androgen receptor activity—CARM1—psoriasis	0.000177	0.00739	CbGpPWpGaD
Adapalene—Skin exfoliation—Acitretin—psoriasis	0.000177	0.00288	CcSEcCtD
Adapalene—RXRA—Mitochondrial biogenesis—CARM1—psoriasis	0.000174	0.00728	CbGpPWpGaD
Adapalene—RXRA—Circadian Clock—CARM1—psoriasis	0.000172	0.00718	CbGpPWpGaD
Adapalene—Vesiculobullous rash—Mycophenolate mofetil—psoriasis	0.000171	0.00279	CcSEcCtD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—LEP—psoriasis	0.000171	0.00714	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000169	0.00708	CbGpPWpGaD
Adapalene—Erythema—Tazarotene—psoriasis	0.000169	0.00275	CcSEcCtD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—VDR—psoriasis	0.000166	0.00696	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000165	0.0069	CbGpPWpGaD
Adapalene—Optic neuritis—Cyclosporine—psoriasis	0.00016	0.0026	CcSEcCtD
Adapalene—Pain—Calcipotriol—psoriasis	0.00016	0.0026	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000158	0.00662	CbGpPWpGaD
Adapalene—Dermatitis bullous—Calcitriol—psoriasis	0.000158	0.00257	CcSEcCtD
Adapalene—Dry skin—Methoxsalen—psoriasis	0.000155	0.00253	CcSEcCtD
Adapalene—RXRG—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000155	0.00648	CbGpPWpGaD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000154	0.00645	CbGpPWpGaD
Adapalene—Rash pustular—Mycophenolic acid—psoriasis	0.000152	0.00248	CcSEcCtD
Adapalene—RARB—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000152	0.00635	CbGpPWpGaD
Adapalene—Eczema—Acitretin—psoriasis	0.000149	0.00243	CcSEcCtD
Adapalene—Eczema—Fluocinolone Acetonide—psoriasis	0.000149	0.00243	CcSEcCtD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—PPARG—psoriasis	0.000149	0.00622	CbGpPWpGaD
Adapalene—Eye pain—Acitretin—psoriasis	0.000149	0.00242	CcSEcCtD
Adapalene—Eye pain—Fluocinolone Acetonide—psoriasis	0.000148	0.00242	CcSEcCtD
Adapalene—Keratitis—Mycophenolate mofetil—psoriasis	0.000148	0.00241	CcSEcCtD
Adapalene—RARA—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000146	0.00609	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000146	0.00609	CbGpPWpGaD
Adapalene—Optic neuritis—Prednisolone—psoriasis	0.000146	0.00237	CcSEcCtD
Adapalene—Erythema—Clobetasol propionate—psoriasis	0.000143	0.00233	CcSEcCtD
Adapalene—Dermatitis exfoliative—Acitretin—psoriasis	0.000142	0.00232	CcSEcCtD
Adapalene—Optic neuritis—Hydrocortisone—psoriasis	0.000142	0.00232	CcSEcCtD
Adapalene—Burning sensation—Cyclosporine—psoriasis	0.000142	0.00231	CcSEcCtD
Adapalene—RXRA—Biological oxidations—CYP2S1—psoriasis	0.000141	0.0059	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000141	0.0059	CbGpPWpGaD
Adapalene—Seborrhoeic dermatitis—Mycophenolate mofetil—psoriasis	0.000141	0.00229	CcSEcCtD
Adapalene—Dermatitis bullous—Acitretin—psoriasis	0.00014	0.00229	CcSEcCtD
Adapalene—Skin exfoliation—Hydroxyurea—psoriasis	0.000139	0.00226	CcSEcCtD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000138	0.00578	CbGpPWpGaD
Adapalene—Keratitis—Prednisolone—psoriasis	0.000138	0.00225	CcSEcCtD
Adapalene—RXRA—Nuclear Receptors—VDR—psoriasis	0.000138	0.00576	CbGpPWpGaD
Adapalene—Hypersensitivity—Calcipotriol—psoriasis	0.000138	0.00224	CcSEcCtD
Adapalene—Optic neuritis—Triamcinolone—psoriasis	0.000134	0.00218	CcSEcCtD
Adapalene—Photosensitivity reaction—Methoxsalen—psoriasis	0.000134	0.00218	CcSEcCtD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000133	0.00554	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000133	0.00554	CbGpPWpGaD
Adapalene—Pruritus—Calcipotriol—psoriasis	0.000132	0.00215	CcSEcCtD
Adapalene—Herpes simplex—Mycophenolic acid—psoriasis	0.000132	0.00215	CcSEcCtD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—CARM1—psoriasis	0.000131	0.00548	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.00013	0.00544	CbGpPWpGaD
Adapalene—Redness—Hydrocortisone—psoriasis	0.000129	0.00211	CcSEcCtD
Adapalene—Erythema—Fluocinonide—psoriasis	0.000129	0.0021	CcSEcCtD
Adapalene—Feeling hot—Cyclosporine—psoriasis	0.000125	0.00204	CcSEcCtD
Adapalene—Dry skin—Acitretin—psoriasis	0.000123	0.002	CcSEcCtD
Adapalene—Optic neuritis—Dexamethasone—psoriasis	0.000121	0.00198	CcSEcCtD
Adapalene—Optic neuritis—Betamethasone—psoriasis	0.000121	0.00198	CcSEcCtD
Adapalene—Stinging—Cyclosporine—psoriasis	0.000121	0.00198	CcSEcCtD
Adapalene—Dermatitis atopic—Prednisolone—psoriasis	0.000121	0.00197	CcSEcCtD
Adapalene—Rash pustular—Mycophenolate mofetil—psoriasis	0.00012	0.00196	CcSEcCtD
Adapalene—Angioedema—Beclomethasone—psoriasis	0.000119	0.00194	CcSEcCtD
Adapalene—Rash—Calcipotriol—psoriasis	0.000118	0.00192	CcSEcCtD
Adapalene—Pain—Tazarotene—psoriasis	0.000118	0.00192	CcSEcCtD
Adapalene—Dermatitis—Calcipotriol—psoriasis	0.000118	0.00192	CcSEcCtD
Adapalene—Keratitis—Betamethasone—psoriasis	0.000115	0.00188	CcSEcCtD
Adapalene—Keratitis—Dexamethasone—psoriasis	0.000115	0.00188	CcSEcCtD
Adapalene—RXRG—Adipogenesis—SOCS1—psoriasis	0.000114	0.00477	CbGpPWpGaD
Adapalene—Conjunctivitis—Calcitriol—psoriasis	0.000113	0.00184	CcSEcCtD
Adapalene—Dermatitis atopic—Triamcinolone—psoriasis	0.000111	0.00181	CcSEcCtD
Adapalene—Stinging—Prednisolone—psoriasis	0.00011	0.0018	CcSEcCtD
Adapalene—Dermatitis bullous—Hydroxyurea—psoriasis	0.00011	0.0018	CcSEcCtD
Adapalene—RXRA—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000109	0.00455	CbGpPWpGaD
Adapalene—Stinging—Hydrocortisone—psoriasis	0.000108	0.00176	CcSEcCtD
Adapalene—RARG—Gene Expression—TARS—psoriasis	0.000108	0.0045	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—SOCS1—psoriasis	0.000107	0.00448	CbGpPWpGaD
Adapalene—Herpes simplex—Cyclosporine—psoriasis	0.000107	0.00174	CcSEcCtD
Adapalene—RXRG—Regulation of Androgen receptor activity—JUN—psoriasis	0.000107	0.00445	CbGpPWpGaD
Adapalene—Skin discolouration—Mycophenolate mofetil—psoriasis	0.000106	0.00173	CcSEcCtD
Adapalene—Photosensitivity reaction—Acitretin—psoriasis	0.000106	0.00172	CcSEcCtD
Adapalene—Optic neuritis—Prednisone—psoriasis	0.000106	0.00172	CcSEcCtD
Adapalene—Herpes simplex—Mycophenolate mofetil—psoriasis	0.000104	0.0017	CcSEcCtD
Adapalene—RXRA—Orphan transporters—CARM1—psoriasis	0.000103	0.00431	CbGpPWpGaD
Adapalene—Erythema—Methoxsalen—psoriasis	0.000102	0.00166	CcSEcCtD
Adapalene—Face oedema—Hydroxyurea—psoriasis	0.000102	0.00166	CcSEcCtD
Adapalene—Stinging—Triamcinolone—psoriasis	0.000102	0.00166	CcSEcCtD
Adapalene—Conjunctivitis—Acitretin—psoriasis	0.000101	0.00164	CcSEcCtD
Adapalene—RXRB—Regulation of Androgen receptor activity—JUN—psoriasis	0.0001	0.00419	CbGpPWpGaD
Adapalene—Pain—Clobetasol propionate—psoriasis	9.99e-05	0.00163	CcSEcCtD
Adapalene—RXRA—PPARA activates gene expression—CARM1—psoriasis	9.86e-05	0.00412	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—TARS—psoriasis	9.83e-05	0.00411	CbGpPWpGaD
Adapalene—Pruritus—Tazarotene—psoriasis	9.75e-05	0.00159	CcSEcCtD
Adapalene—Herpes simplex—Prednisolone—psoriasis	9.71e-05	0.00158	CcSEcCtD
Adapalene—Skin discolouration—Hydrocortisone—psoriasis	9.68e-05	0.00158	CcSEcCtD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	9.65e-05	0.00403	CbGpPWpGaD
Adapalene—RARB—Gene Expression—TARS—psoriasis	9.64e-05	0.00403	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptors—PPARG—psoriasis	9.6e-05	0.00402	CbGpPWpGaD
Adapalene—Hepatitis—Acitretin—psoriasis	9.29e-05	0.00151	CcSEcCtD
Adapalene—RXRB—Gene Expression—TARS—psoriasis	9.25e-05	0.00387	CbGpPWpGaD
Adapalene—RARA—Gene Expression—TARS—psoriasis	9.25e-05	0.00387	CbGpPWpGaD
Adapalene—Dermatitis bullous—Mycophenolic acid—psoriasis	9.23e-05	0.0015	CcSEcCtD
Adapalene—Stinging—Betamethasone—psoriasis	9.22e-05	0.0015	CcSEcCtD
Adapalene—Stinging—Dexamethasone—psoriasis	9.22e-05	0.0015	CcSEcCtD
Adapalene—Pain—Beclomethasone—psoriasis	9.1e-05	0.00148	CcSEcCtD
Adapalene—Erythema—Calcitriol—psoriasis	9.09e-05	0.00148	CcSEcCtD
Adapalene—Pain—Fluocinonide—psoriasis	9.01e-05	0.00147	CcSEcCtD
Adapalene—Dermatitis atopic—Prednisone—psoriasis	8.79e-05	0.00143	CcSEcCtD
Adapalene—Rash—Tazarotene—psoriasis	8.69e-05	0.00142	CcSEcCtD
Adapalene—Dermatitis—Tazarotene—psoriasis	8.68e-05	0.00141	CcSEcCtD
Adapalene—Dermatitis contact—Hydrocortisone—psoriasis	8.64e-05	0.00141	CcSEcCtD
Adapalene—Hypersensitivity—Clobetasol propionate—psoriasis	8.61e-05	0.0014	CcSEcCtD
Adapalene—Face oedema—Mycophenolic acid—psoriasis	8.52e-05	0.00139	CcSEcCtD
Adapalene—Urticaria—Beclomethasone—psoriasis	8.45e-05	0.00138	CcSEcCtD
Adapalene—RXRG—Adipogenesis—LEP—psoriasis	8.41e-05	0.00352	CbGpPWpGaD
Adapalene—Skin exfoliation—Hydrocortisone—psoriasis	8.35e-05	0.00136	CcSEcCtD
Adapalene—Pruritus—Clobetasol propionate—psoriasis	8.27e-05	0.00135	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	8.25e-05	0.00345	CbGpPWpGaD
Adapalene—Dermatitis contact—Triamcinolone—psoriasis	8.13e-05	0.00133	CcSEcCtD
Adapalene—Herpes simplex—Dexamethasone—psoriasis	8.1e-05	0.00132	CcSEcCtD
Adapalene—Herpes simplex—Betamethasone—psoriasis	8.1e-05	0.00132	CcSEcCtD
Adapalene—Erythema—Acitretin—psoriasis	8.08e-05	0.00132	CcSEcCtD
Adapalene—Erythema—Fluocinolone Acetonide—psoriasis	8.06e-05	0.00131	CcSEcCtD
Adapalene—Eczema—Cyclosporine—psoriasis	7.94e-05	0.00129	CcSEcCtD
Adapalene—RARA—Adipogenesis—LEP—psoriasis	7.91e-05	0.00331	CbGpPWpGaD
Adapalene—Eye pain—Cyclosporine—psoriasis	7.91e-05	0.00129	CcSEcCtD
Adapalene—RXRA—Organelle biogenesis and maintenance—CARM1—psoriasis	7.9e-05	0.0033	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—TNF—psoriasis	7.9e-05	0.0033	CbGpPWpGaD
Adapalene—Convulsion—Calcitriol—psoriasis	7.87e-05	0.00128	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—TGFA—psoriasis	7.86e-05	0.00329	CbGpPWpGaD
Adapalene—Skin exfoliation—Triamcinolone—psoriasis	7.86e-05	0.00128	CcSEcCtD
Adapalene—Burning sensation—Methotrexate—psoriasis	7.82e-05	0.00127	CcSEcCtD
Adapalene—Hypersensitivity—Fluocinonide—psoriasis	7.77e-05	0.00127	CcSEcCtD
Adapalene—Eye pain—Mycophenolate mofetil—psoriasis	7.72e-05	0.00126	CcSEcCtD
Adapalene—RXRA—Nuclear Receptor transcription pathway—PPARG—psoriasis	7.59e-05	0.00317	CbGpPWpGaD
Adapalene—Dermatitis bullous—Cyclosporine—psoriasis	7.47e-05	0.00122	CcSEcCtD
Adapalene—Pruritus—Fluocinonide—psoriasis	7.46e-05	0.00121	CcSEcCtD
Adapalene—Angioedema—Acitretin—psoriasis	7.39e-05	0.0012	CcSEcCtD
Adapalene—Dermatitis contact—Betamethasone—psoriasis	7.38e-05	0.0012	CcSEcCtD
Adapalene—Dermatitis contact—Dexamethasone—psoriasis	7.38e-05	0.0012	CcSEcCtD
Adapalene—Rash—Clobetasol propionate—psoriasis	7.37e-05	0.0012	CcSEcCtD
Adapalene—Dermatitis—Clobetasol propionate—psoriasis	7.36e-05	0.0012	CcSEcCtD
Adapalene—RXRG—Adipogenesis—PPARG—psoriasis	7.33e-05	0.00306	CbGpPWpGaD
Adapalene—Dermatitis bullous—Mycophenolate mofetil—psoriasis	7.29e-05	0.00119	CcSEcCtD
Adapalene—Skin exfoliation—Betamethasone—psoriasis	7.13e-05	0.00116	CcSEcCtD
Adapalene—Skin exfoliation—Dexamethasone—psoriasis	7.13e-05	0.00116	CcSEcCtD
Adapalene—Eczema—Hydrocortisone—psoriasis	7.06e-05	0.00115	CcSEcCtD
Adapalene—RARG—Generic Transcription Pathway—CARM1—psoriasis	7.03e-05	0.00294	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	6.91e-05	0.00289	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—PPARG—psoriasis	6.89e-05	0.00288	CbGpPWpGaD
Adapalene—Dermatitis bullous—Prednisolone—psoriasis	6.8e-05	0.00111	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	6.73e-05	0.00281	CbGpPWpGaD
Adapalene—Face oedema—Mycophenolate mofetil—psoriasis	6.72e-05	0.0011	CcSEcCtD
Adapalene—Rash—Beclomethasone—psoriasis	6.71e-05	0.00109	CcSEcCtD
Adapalene—Dermatitis—Beclomethasone—psoriasis	6.7e-05	0.00109	CcSEcCtD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	6.65e-05	0.00278	CbGpPWpGaD
Adapalene—Rash—Fluocinonide—psoriasis	6.65e-05	0.00108	CcSEcCtD
Adapalene—Dermatitis—Fluocinonide—psoriasis	6.64e-05	0.00108	CcSEcCtD
Adapalene—Conjunctivitis—Mycophenolic acid—psoriasis	6.61e-05	0.00108	CcSEcCtD
Adapalene—Urticaria—Methoxsalen—psoriasis	6.61e-05	0.00108	CcSEcCtD
Adapalene—Dry skin—Cyclosporine—psoriasis	6.54e-05	0.00107	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	6.45e-05	0.0027	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—CARM1—psoriasis	6.43e-05	0.00269	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—IL6—psoriasis	6.37e-05	0.00266	CbGpPWpGaD
Adapalene—Erythema—Hydroxyurea—psoriasis	6.35e-05	0.00103	CcSEcCtD
Adapalene—Pain—Calcitriol—psoriasis	6.34e-05	0.00103	CcSEcCtD
Adapalene—RARB—Generic Transcription Pathway—CARM1—psoriasis	6.3e-05	0.00264	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—psoriasis	6.27e-05	0.00262	CbGpPWpGaD
Adapalene—Dermatitis bullous—Triamcinolone—psoriasis	6.25e-05	0.00102	CcSEcCtD
Adapalene—Skin exfoliation—Prednisone—psoriasis	6.21e-05	0.00101	CcSEcCtD
Adapalene—Hypersensitivity—Methoxsalen—psoriasis	6.13e-05	0.000999	CcSEcCtD
Adapalene—Hepatitis—Mycophenolic acid—psoriasis	6.11e-05	0.000995	CcSEcCtD
Adapalene—RXRB—Generic Transcription Pathway—CARM1—psoriasis	6.04e-05	0.00253	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—CARM1—psoriasis	6.04e-05	0.00253	CbGpPWpGaD
Adapalene—Skin discolouration—Methotrexate—psoriasis	6.02e-05	0.00098	CcSEcCtD
Adapalene—Eye pain—Dexamethasone—psoriasis	6.01e-05	0.000978	CcSEcCtD
Adapalene—Eye pain—Betamethasone—psoriasis	6.01e-05	0.000978	CcSEcCtD
Adapalene—Dry skin—Prednisolone—psoriasis	5.96e-05	0.00097	CcSEcCtD
Adapalene—Herpes simplex—Methotrexate—psoriasis	5.9e-05	0.000961	CcSEcCtD
Adapalene—Urticaria—Calcitriol—psoriasis	5.89e-05	0.00096	CcSEcCtD
Adapalene—Pruritus—Methoxsalen—psoriasis	5.89e-05	0.000959	CcSEcCtD
Adapalene—Dry skin—Hydrocortisone—psoriasis	5.82e-05	0.000948	CcSEcCtD
Adapalene—Dermatitis bullous—Betamethasone—psoriasis	5.67e-05	0.000924	CcSEcCtD
Adapalene—Dermatitis bullous—Dexamethasone—psoriasis	5.67e-05	0.000924	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	5.65e-05	0.00236	CbGpPWpGaD
Adapalene—Pain—Acitretin—psoriasis	5.64e-05	0.000919	CcSEcCtD
Adapalene—Pain—Fluocinolone Acetonide—psoriasis	5.63e-05	0.000916	CcSEcCtD
Adapalene—RXRA—Adipogenesis—SOCS1—psoriasis	5.59e-05	0.00234	CbGpPWpGaD
Adapalene—Convulsion—Hydroxyurea—psoriasis	5.5e-05	0.000896	CcSEcCtD
Adapalene—Hypersensitivity—Calcitriol—psoriasis	5.46e-05	0.00089	CcSEcCtD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	5.46e-05	0.00228	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	5.42e-05	0.00227	CbGpPWpGaD
Adapalene—Conjunctivitis—Cyclosporine—psoriasis	5.35e-05	0.000871	CcSEcCtD
Adapalene—Pruritus—Calcitriol—psoriasis	5.25e-05	0.000855	CcSEcCtD
Adapalene—Rash—Methoxsalen—psoriasis	5.25e-05	0.000855	CcSEcCtD
Adapalene—Dermatitis—Methoxsalen—psoriasis	5.24e-05	0.000854	CcSEcCtD
Adapalene—Urticaria—Acitretin—psoriasis	5.24e-05	0.000854	CcSEcCtD
Adapalene—RXRA—Regulation of Androgen receptor activity—JUN—psoriasis	5.22e-05	0.00218	CbGpPWpGaD
Adapalene—Conjunctivitis—Mycophenolate mofetil—psoriasis	5.22e-05	0.00085	CcSEcCtD
Adapalene—Skin exfoliation—Methotrexate—psoriasis	5.19e-05	0.000845	CcSEcCtD
Adapalene—Dry skin—Dexamethasone—psoriasis	4.97e-05	0.00081	CcSEcCtD
Adapalene—Dry skin—Betamethasone—psoriasis	4.97e-05	0.00081	CcSEcCtD
Adapalene—Hepatitis—Cyclosporine—psoriasis	4.94e-05	0.000805	CcSEcCtD
Adapalene—Conjunctivitis—Prednisolone—psoriasis	4.87e-05	0.000793	CcSEcCtD
Adapalene—Hypersensitivity—Acitretin—psoriasis	4.86e-05	0.000792	CcSEcCtD
Adapalene—Hypersensitivity—Fluocinolone Acetonide—psoriasis	4.85e-05	0.00079	CcSEcCtD
Adapalene—RXRA—Gene Expression—TARS—psoriasis	4.82e-05	0.00201	CbGpPWpGaD
Adapalene—Hepatitis—Mycophenolate mofetil—psoriasis	4.82e-05	0.000785	CcSEcCtD
Adapalene—Rash—Calcitriol—psoriasis	4.68e-05	0.000762	CcSEcCtD
Adapalene—Dermatitis—Calcitriol—psoriasis	4.67e-05	0.000761	CcSEcCtD
Adapalene—Pruritus—Acitretin—psoriasis	4.67e-05	0.00076	CcSEcCtD
Adapalene—Pruritus—Fluocinolone Acetonide—psoriasis	4.65e-05	0.000758	CcSEcCtD
Adapalene—Convulsion—Mycophenolic acid—psoriasis	4.61e-05	0.00075	CcSEcCtD
Adapalene—Face oedema—Prednisone—psoriasis	4.56e-05	0.000743	CcSEcCtD
Adapalene—RXRG—Adipogenesis—STAT3—psoriasis	4.5e-05	0.00188	CbGpPWpGaD
Adapalene—Conjunctivitis—Triamcinolone—psoriasis	4.48e-05	0.000729	CcSEcCtD
Adapalene—Pain—Hydroxyurea—psoriasis	4.43e-05	0.000721	CcSEcCtD
Adapalene—Dry skin—Prednisone—psoriasis	4.33e-05	0.000705	CcSEcCtD
Adapalene—RARA—Adipogenesis—STAT3—psoriasis	4.23e-05	0.00177	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—VDR—psoriasis	4.2e-05	0.00175	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Methotrexate—psoriasis	4.18e-05	0.000681	CcSEcCtD
Adapalene—Rash—Acitretin—psoriasis	4.16e-05	0.000678	CcSEcCtD
Adapalene—Dermatitis—Acitretin—psoriasis	4.16e-05	0.000677	CcSEcCtD
Adapalene—Rash—Fluocinolone Acetonide—psoriasis	4.15e-05	0.000676	CcSEcCtD
Adapalene—Dermatitis—Fluocinolone Acetonide—psoriasis	4.14e-05	0.000675	CcSEcCtD
Adapalene—RXRA—Adipogenesis—LEP—psoriasis	4.12e-05	0.00172	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—PPARG—psoriasis	4.1e-05	0.00172	CbGpPWpGaD
Adapalene—Conjunctivitis—Betamethasone—psoriasis	4.06e-05	0.000662	CcSEcCtD
Adapalene—Conjunctivitis—Dexamethasone—psoriasis	4.06e-05	0.000662	CcSEcCtD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	4.02e-05	0.00168	CbGpPWpGaD
Adapalene—Angioedema—Cyclosporine—psoriasis	3.93e-05	0.00064	CcSEcCtD
Adapalene—Erythema—Prednisolone—psoriasis	3.91e-05	0.000637	CcSEcCtD
Adapalene—RXRG—Adipogenesis—TNF—psoriasis	3.89e-05	0.00163	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—VDR—psoriasis	3.84e-05	0.0016	CbGpPWpGaD
Adapalene—Angioedema—Mycophenolate mofetil—psoriasis	3.83e-05	0.000624	CcSEcCtD
Adapalene—Erythema—Hydrocortisone—psoriasis	3.82e-05	0.000623	CcSEcCtD
Adapalene—Hypersensitivity—Hydroxyurea—psoriasis	3.82e-05	0.000622	CcSEcCtD
Adapalene—RARB—Generic Transcription Pathway—VDR—psoriasis	3.76e-05	0.00157	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.75e-05	0.00157	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	3.73e-05	0.00156	CbGpPWpGaD
Adapalene—Convulsion—Cyclosporine—psoriasis	3.73e-05	0.000607	CcSEcCtD
Adapalene—Pain—Mycophenolic acid—psoriasis	3.71e-05	0.000604	CcSEcCtD
Adapalene—RARA—Adipogenesis—TNF—psoriasis	3.66e-05	0.00153	CbGpPWpGaD
Adapalene—Convulsion—Mycophenolate mofetil—psoriasis	3.63e-05	0.000592	CcSEcCtD
Adapalene—RARA—Generic Transcription Pathway—VDR—psoriasis	3.61e-05	0.00151	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—VDR—psoriasis	3.61e-05	0.00151	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.61e-05	0.00151	CbGpPWpGaD
Adapalene—Erythema—Triamcinolone—psoriasis	3.6e-05	0.000586	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.59e-05	0.0015	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—PPARG—psoriasis	3.59e-05	0.0015	CbGpPWpGaD
Adapalene—Angioedema—Prednisolone—psoriasis	3.58e-05	0.000582	CcSEcCtD
Adapalene—Angioedema—Hydrocortisone—psoriasis	3.49e-05	0.000569	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.46e-05	0.00145	CbGpPWpGaD
Adapalene—Convulsion—Prednisolone—psoriasis	3.39e-05	0.000552	CcSEcCtD
Adapalene—RARG—Gene Expression—CARM1—psoriasis	3.38e-05	0.00141	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.36e-05	0.00141	CbGpPWpGaD
Adapalene—Convulsion—Hydrocortisone—psoriasis	3.31e-05	0.000539	CcSEcCtD
Adapalene—Angioedema—Triamcinolone—psoriasis	3.29e-05	0.000536	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.27e-05	0.00137	CbGpPWpGaD
Adapalene—Rash—Hydroxyurea—psoriasis	3.27e-05	0.000532	CcSEcCtD
Adapalene—Erythema—Dexamethasone—psoriasis	3.26e-05	0.000532	CcSEcCtD
Adapalene—Erythema—Betamethasone—psoriasis	3.26e-05	0.000532	CcSEcCtD
Adapalene—Dermatitis—Hydroxyurea—psoriasis	3.26e-05	0.000531	CcSEcCtD
Adapalene—RXRA—Generic Transcription Pathway—CARM1—psoriasis	3.15e-05	0.00132	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—IL6—psoriasis	3.14e-05	0.00131	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.14e-05	0.00131	CbGpPWpGaD
Adapalene—Convulsion—Triamcinolone—psoriasis	3.12e-05	0.000508	CcSEcCtD
Adapalene—Photosensitivity reaction—Methotrexate—psoriasis	3.11e-05	0.000507	CcSEcCtD
Adapalene—RXRG—Gene Expression—CARM1—psoriasis	3.09e-05	0.00129	CbGpPWpGaD
Adapalene—Pruritus—Mycophenolic acid—psoriasis	3.07e-05	0.0005	CcSEcCtD
Adapalene—RARB—Gene Expression—CARM1—psoriasis	3.03e-05	0.00127	CbGpPWpGaD
Adapalene—Pain—Cyclosporine—psoriasis	3e-05	0.000489	CcSEcCtD
Adapalene—Angioedema—Dexamethasone—psoriasis	2.98e-05	0.000486	CcSEcCtD
Adapalene—Angioedema—Betamethasone—psoriasis	2.98e-05	0.000486	CcSEcCtD
Adapalene—RXRA—Developmental Biology—CARM1—psoriasis	2.96e-05	0.00124	CbGpPWpGaD
Adapalene—Conjunctivitis—Methotrexate—psoriasis	2.96e-05	0.000481	CcSEcCtD
Adapalene—RARA—Adipogenesis—IL6—psoriasis	2.95e-05	0.00123	CbGpPWpGaD
Adapalene—Pain—Mycophenolate mofetil—psoriasis	2.93e-05	0.000477	CcSEcCtD
Adapalene—RARG—Generic Transcription Pathway—PPARG—psoriasis	2.93e-05	0.00122	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—CARM1—psoriasis	2.91e-05	0.00122	CbGpPWpGaD
Adapalene—RARA—Gene Expression—CARM1—psoriasis	2.91e-05	0.00122	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—psoriasis	2.9e-05	0.00121	CbGpPWpGaD
Adapalene—Erythema—Prednisone—psoriasis	2.84e-05	0.000463	CcSEcCtD
Adapalene—RXRA—Metabolism—NDUFA5—psoriasis	2.84e-05	0.00119	CbGpPWpGaD
Adapalene—Convulsion—Dexamethasone—psoriasis	2.83e-05	0.000461	CcSEcCtD
Adapalene—Convulsion—Betamethasone—psoriasis	2.83e-05	0.000461	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.82e-05	0.00118	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.81e-05	0.00117	CbGpPWpGaD
Adapalene—Urticaria—Cyclosporine—psoriasis	2.79e-05	0.000454	CcSEcCtD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	2.77e-05	0.00116	CbGpPWpGaD
Adapalene—Rash—Mycophenolic acid—psoriasis	2.74e-05	0.000446	CcSEcCtD
Adapalene—Dermatitis—Mycophenolic acid—psoriasis	2.73e-05	0.000445	CcSEcCtD
Adapalene—Pain—Prednisolone—psoriasis	2.73e-05	0.000445	CcSEcCtD
Adapalene—Hepatitis—Methotrexate—psoriasis	2.73e-05	0.000445	CcSEcCtD
Adapalene—Urticaria—Mycophenolate mofetil—psoriasis	2.72e-05	0.000443	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.69e-05	0.00112	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—PPARG—psoriasis	2.68e-05	0.00112	CbGpPWpGaD
Adapalene—Pain—Hydrocortisone—psoriasis	2.67e-05	0.000434	CcSEcCtD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.65e-05	0.00111	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—CP—psoriasis	2.64e-05	0.0011	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—PPARG—psoriasis	2.62e-05	0.0011	CbGpPWpGaD
Adapalene—Angioedema—Prednisone—psoriasis	2.6e-05	0.000423	CcSEcCtD
Adapalene—Hypersensitivity—Cyclosporine—psoriasis	2.59e-05	0.000421	CcSEcCtD
Adapalene—Urticaria—Prednisolone—psoriasis	2.54e-05	0.000413	CcSEcCtD
Adapalene—Hypersensitivity—Mycophenolate mofetil—psoriasis	2.52e-05	0.000411	CcSEcCtD
Adapalene—RXRA—Transmembrane transport of small molecules—CARM1—psoriasis	2.52e-05	0.00105	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—PPARG—psoriasis	2.52e-05	0.00105	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—PPARG—psoriasis	2.52e-05	0.00105	CbGpPWpGaD
Adapalene—Pain—Triamcinolone—psoriasis	2.51e-05	0.000409	CcSEcCtD
Adapalene—Pruritus—Cyclosporine—psoriasis	2.48e-05	0.000404	CcSEcCtD
Adapalene—Urticaria—Hydrocortisone—psoriasis	2.48e-05	0.000404	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.47e-05	0.00103	CbGpPWpGaD
Adapalene—Convulsion—Prednisone—psoriasis	2.46e-05	0.000401	CcSEcCtD
Adapalene—Pruritus—Mycophenolate mofetil—psoriasis	2.42e-05	0.000395	CcSEcCtD
Adapalene—RXRA—Metabolism—CYP2S1—psoriasis	2.41e-05	0.00101	CbGpPWpGaD
Adapalene—Erythema—Methotrexate—psoriasis	2.38e-05	0.000387	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.37e-05	0.000991	CbGpPWpGaD
Adapalene—Hypersensitivity—Prednisolone—psoriasis	2.35e-05	0.000383	CcSEcCtD
Adapalene—Urticaria—Triamcinolone—psoriasis	2.33e-05	0.00038	CcSEcCtD
Adapalene—Hypersensitivity—Hydrocortisone—psoriasis	2.3e-05	0.000374	CcSEcCtD
Adapalene—Pain—Dexamethasone—psoriasis	2.28e-05	0.000371	CcSEcCtD
Adapalene—Pain—Betamethasone—psoriasis	2.28e-05	0.000371	CcSEcCtD
Adapalene—Rash—Cyclosporine—psoriasis	2.21e-05	0.00036	CcSEcCtD
Adapalene—Dermatitis—Cyclosporine—psoriasis	2.21e-05	0.00036	CcSEcCtD
Adapalene—Pruritus—Hydrocortisone—psoriasis	2.21e-05	0.000359	CcSEcCtD
Adapalene—RXRA—Adipogenesis—STAT3—psoriasis	2.2e-05	0.000921	CbGpPWpGaD
Adapalene—Hypersensitivity—Triamcinolone—psoriasis	2.16e-05	0.000352	CcSEcCtD
Adapalene—Rash—Mycophenolate mofetil—psoriasis	2.16e-05	0.000352	CcSEcCtD
Adapalene—Dermatitis—Mycophenolate mofetil—psoriasis	2.16e-05	0.000351	CcSEcCtD
Adapalene—Urticaria—Betamethasone—psoriasis	2.12e-05	0.000345	CcSEcCtD
Adapalene—Urticaria—Dexamethasone—psoriasis	2.12e-05	0.000345	CcSEcCtD
Adapalene—Pruritus—Triamcinolone—psoriasis	2.08e-05	0.000338	CcSEcCtD
Adapalene—Convulsion—Methotrexate—psoriasis	2.06e-05	0.000335	CcSEcCtD
Adapalene—RARG—Gene Expression—VDR—psoriasis	2.02e-05	0.000845	CbGpPWpGaD
Adapalene—Rash—Prednisolone—psoriasis	2.01e-05	0.000328	CcSEcCtD
Adapalene—Dermatitis—Prednisolone—psoriasis	2.01e-05	0.000328	CcSEcCtD
Adapalene—Rash—Hydrocortisone—psoriasis	1.97e-05	0.00032	CcSEcCtD
Adapalene—Dermatitis—Hydrocortisone—psoriasis	1.96e-05	0.00032	CcSEcCtD
Adapalene—RXRA—Adipogenesis—TNF—psoriasis	1.91e-05	0.000797	CbGpPWpGaD
Adapalene—Pruritus—Dexamethasone—psoriasis	1.89e-05	0.000307	CcSEcCtD
Adapalene—Pruritus—Betamethasone—psoriasis	1.89e-05	0.000307	CcSEcCtD
Adapalene—RXRA—Generic Transcription Pathway—VDR—psoriasis	1.88e-05	0.000786	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.87e-05	0.000783	CbGpPWpGaD
Adapalene—Rash—Triamcinolone—psoriasis	1.85e-05	0.000302	CcSEcCtD
Adapalene—Dermatitis—Triamcinolone—psoriasis	1.85e-05	0.000301	CcSEcCtD
Adapalene—RXRG—Gene Expression—VDR—psoriasis	1.85e-05	0.000773	CbGpPWpGaD
Adapalene—Urticaria—Prednisone—psoriasis	1.84e-05	0.0003	CcSEcCtD
Adapalene—RARB—Gene Expression—VDR—psoriasis	1.81e-05	0.000758	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.8e-05	0.000753	CbGpPWpGaD
Adapalene—RARA—Gene Expression—VDR—psoriasis	1.74e-05	0.000726	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—VDR—psoriasis	1.74e-05	0.000726	CbGpPWpGaD
Adapalene—Hypersensitivity—Prednisone—psoriasis	1.71e-05	0.000279	CcSEcCtD
Adapalene—Rash—Betamethasone—psoriasis	1.68e-05	0.000274	CcSEcCtD
Adapalene—Rash—Dexamethasone—psoriasis	1.68e-05	0.000274	CcSEcCtD
Adapalene—Dermatitis—Dexamethasone—psoriasis	1.68e-05	0.000273	CcSEcCtD
Adapalene—Dermatitis—Betamethasone—psoriasis	1.68e-05	0.000273	CcSEcCtD
Adapalene—Pain—Methotrexate—psoriasis	1.66e-05	0.00027	CcSEcCtD
Adapalene—Pruritus—Prednisone—psoriasis	1.64e-05	0.000267	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.64e-05	0.000684	CbGpPWpGaD
Adapalene—Urticaria—Methotrexate—psoriasis	1.54e-05	0.000251	CcSEcCtD
Adapalene—RXRA—Adipogenesis—IL6—psoriasis	1.54e-05	0.000643	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—CARM1—psoriasis	1.52e-05	0.000634	CbGpPWpGaD
Adapalene—Rash—Prednisone—psoriasis	1.46e-05	0.000238	CcSEcCtD
Adapalene—Dermatitis—Prednisone—psoriasis	1.46e-05	0.000238	CcSEcCtD
Adapalene—Hypersensitivity—Methotrexate—psoriasis	1.43e-05	0.000233	CcSEcCtD
Adapalene—RXRA—Developmental Biology—LEP—psoriasis	1.42e-05	0.000592	CbGpPWpGaD
Adapalene—RARG—Gene Expression—PPARG—psoriasis	1.41e-05	0.000589	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.4e-05	0.000586	CbGpPWpGaD
Adapalene—Pruritus—Methotrexate—psoriasis	1.37e-05	0.000224	CcSEcCtD
Adapalene—RXRA—Generic Transcription Pathway—PPARG—psoriasis	1.31e-05	0.000548	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—PPARG—psoriasis	1.29e-05	0.000539	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.27e-05	0.000529	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PPARG—psoriasis	1.26e-05	0.000528	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.24e-05	0.000517	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PPARG—psoriasis	1.23e-05	0.000516	CbGpPWpGaD
Adapalene—Rash—Methotrexate—psoriasis	1.22e-05	0.000199	CcSEcCtD
Adapalene—Dermatitis—Methotrexate—psoriasis	1.22e-05	0.000199	CcSEcCtD
Adapalene—RARA—Gene Expression—PPARG—psoriasis	1.21e-05	0.000506	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PPARG—psoriasis	1.21e-05	0.000506	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CARM1—psoriasis	1.18e-05	0.000493	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.1e-05	0.000461	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TYK2—psoriasis	1.08e-05	0.000452	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—VDR—psoriasis	9.05e-06	0.000379	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—NFKB1—psoriasis	8.43e-06	0.000352	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—VEGFA—psoriasis	7.65e-06	0.00032	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—STAT3—psoriasis	7.57e-06	0.000317	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CAT—psoriasis	7.25e-06	0.000303	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TNF—psoriasis	6.55e-06	0.000274	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PPARG—psoriasis	6.31e-06	0.000264	CbGpPWpGaD
Adapalene—RXRA—Metabolism—APOE—psoriasis	5.64e-06	0.000236	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—IL6—psoriasis	5.29e-06	0.000221	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PPARG—psoriasis	4.91e-06	0.000205	CbGpPWpGaD
